Allergic Conjunctivitis Market, By Type (Bacterial, Allergic, Viral, and Chemical), By Drug Class (Antibiotics, Mast Cell Stabilizers, Steroids, and Others), By End Users (Hospitals and Clinics and Specialty Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2029

Report Code: PMI448920 | Publish Date: June 2023 | No. of Pages: 170

Global Allergic Conjunctivitis Market Companies

  • Akorn Incorporated
  • Allergan
  • Bausch Health Companies, Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharma Advanced Research Company Ltd.
  • Ocular Therapeutix, Inc.
  • Sirion Therapeutics, Inc.
  • Boehringer Ingelheim International GmbH
  • Atopix Therapeutics Ltd.
  • Auven Therapeutics.

Recent News:

  • According to recent research article by PubMed Central, allergic conjunctivitis includes seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC) and giant papillary conjunctivitis (GPC). In general, allergic conditions involve mast cell degranulation that leads to release of inflammatory mediators and activation of enzymatic cascades generating pro-inflammatory mediators.